Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 115

1.

Efficacy of selective transarterial chemoembolization in inducing tumor necrosis in small (<5 cm) hepatocellular carcinomas.

Golfieri R, Cappelli A, Cucchetti A, Piscaglia F, Carpenzano M, Peri E, Ravaioli M, D'Errico-Grigioni A, Pinna AD, Bolondi L.

Hepatology. 2011 May;53(5):1580-9. doi: 10.1002/hep.24246.

PMID:
21351114
2.

Hepatocellular carcinoma responding to superselective transarterial chemoembolization: an issue of nodule dimension?

Golfieri R, Renzulli M, Mosconi C, Forlani L, Giampalma E, Piscaglia F, Trevisani F, Bolondi L; Bologna Liver Oncology Group (BLOG).

J Vasc Interv Radiol. 2013 Apr;24(4):509-17. doi: 10.1016/j.jvir.2012.12.013. Epub 2013 Feb 18.

PMID:
23428355
3.

Response to transarterial chemoembolization as a biological selection criterion for liver transplantation in hepatocellular carcinoma.

Otto G, Herber S, Heise M, Lohse AW, Mönch C, Bittinger F, Hoppe-Lotichius M, Schuchmann M, Victor A, Pitton M.

Liver Transpl. 2006 Aug;12(8):1260-7.

4.

Complete necrosis after transarterial chemoembolization could predict prolonged survival in patients with recurrent intrahepatic hepatocellular carcinoma after curative resection.

Shim JH, Kim KM, Lee YJ, Ko GY, Yoon HK, Sung KB, Park KM, Lee SG, Lim YS, Lee HC, Chung YH, Lee YS, Suh DJ.

Ann Surg Oncol. 2010 Mar;17(3):869-77. doi: 10.1245/s10434-009-0788-7. Epub 2009 Dec 22.

PMID:
20033326
5.

Disease course after liver transplantation for hepatocellular carcinoma in patients with complete tumor necrosis in liver explants after performance of bridging treatments.

Sotiropoulos GC, Malago M, Molmenti EP, Radtke A, Brokalaki EI, Nadalin S, Lang H, Frilling A, Baba HA, Kühl H, Verhagen R, Broelsch CE.

Eur J Med Res. 2005 Dec 7;10(12):539-42.

PMID:
16356871
6.

Comparison of two techniques of transarterial chemoembolization before liver transplantation for hepatocellular carcinoma: a case-control study.

Dharancy S, Boitard J, Decaens T, Sergent G, Boleslawski E, Duvoux C, Vanlemmens C, Meyer C, Gugenheim J, Durand F, Boillot O, Declerck N, Louvet A, Canva V, Romano O, Ernst O, Mathurin P, Pruvot FR.

Liver Transpl. 2007 May;13(5):665-71.

7.

Combined treatment, TACE and RF ablation, in HCC: preliminary results.

Gasparini D, Sponza M, Marzio A, Zanardi R, Bazzocchi M, Cemal Y.

Radiol Med. 2002 Nov-Dec;104(5-6):412-20. English, Italian.

PMID:
12589262
8.

Impact of pretransplantation transarterial chemoembolization on survival and recurrence after liver transplantation for hepatocellular carcinoma.

Decaens T, Roudot-Thoraval F, Bresson-Hadni S, Meyer C, Gugenheim J, Durand F, Bernard PH, Boillot O, Boudjema K, Calmus Y, Hardwigsen J, Ducerf C, Pageaux GP, Dharancy S, Chazouilleres O, Dhumeaux D, Cherqui D, Duvoux C.

Liver Transpl. 2005 Jul;11(7):767-75.

9.

Superselective transarterial chemoembolization for hepatocellular carcinoma. Validation of treatment algorithm proposed by Japanese guidelines.

Takayasu K, Arii S, Kudo M, Ichida T, Matsui O, Izumi N, Matsuyama Y, Sakamoto M, Nakashima O, Ku Y, Kokudo N, Makuuchi M.

J Hepatol. 2012 Apr;56(4):886-92. doi: 10.1016/j.jhep.2011.10.021. Epub 2011 Dec 13.

PMID:
22173160
10.

Histopathologic outcome of neoadjuvant image-guided therapy of hepatocellular carcinoma.

Marin HL, Furth EE, Olthoff K, Shaked A, Soulen MC.

J Gastrointestin Liver Dis. 2009 Jun;18(2):169-76.

11.

Necrosis and apoptosis in hepatocellular carcinoma following low-dose versus high-dose preoperative chemoembolization.

Lu W, Li YH, He XF, Zhao JB, Chen Y, Mei QL.

Cardiovasc Intervent Radiol. 2008 Nov-Dec;31(6):1133-40. doi: 10.1007/s00270-008-9379-4. Epub 2008 Jun 27.

PMID:
18584240
12.

A comparative analysis of transarterial downstaging for hepatocellular carcinoma: chemoembolization versus radioembolization.

Lewandowski RJ, Kulik LM, Riaz A, Senthilnathan S, Mulcahy MF, Ryu RK, Ibrahim SM, Sato KT, Baker T, Miller FH, Omary R, Abecassis M, Salem R.

Am J Transplant. 2009 Aug;9(8):1920-8. doi: 10.1111/j.1600-6143.2009.02695.x. Epub 2009 Jun 22.

13.

Application of DC beads in hepatocellular carcinoma: clinical and radiological results of a drug delivery device for transcatheter superselective arterial embolization.

Sadick M, Haas S, Loehr M, Elshwi M, Singer MV, Brade J, Schoenberg SO, Diehl SJ.

Onkologie. 2010;33(1-2):31-7. doi: 10.1159/000264620. Epub 2010 Jan 22.

PMID:
20164659
14.

Patients with unresectable hepatocellular carcinoma beyond Milan criteria: should we perform transarterial chemoembolization or liver transplantation?

Kim JM, Kwon CH, Joh JW, Kim SJ, Shin M, Kim EY, Moon JI, Jung GO, Choi GS, Lee SK.

Transplant Proc. 2010 Apr;42(3):821-4. doi: 10.1016/j.transproceed.2010.02.027.

PMID:
20430181
15.

Effect of preoperative transcatheter arterial chemoembolization on tumor cell activity in hepatocellular carcinoma.

Huang J, He X, Lin X, Zhang C, Li J.

Chin Med J (Engl). 2000 May;113(5):446-8.

PMID:
11776102
16.

Partial necrosis on hepatocellular carcinoma nodules facilitates tumor recurrence after liver transplantation.

Ravaioli M, Grazi GL, Ercolani G, Fiorentino M, Cescon M, Golfieri R, Trevisani F, Grigioni WF, Bolondi L, Pinna AD.

Transplantation. 2004 Dec 27;78(12):1780-6.

PMID:
15614151
17.

Impact of multiple transarterial chemoembolization treatments on hepatocellular carcinoma for patients awaiting liver transplantation.

Terzi E, Ray Kim W, Sanchez W, Charlton MR, Schmeltzer P, Gores GJ, Andrews JC, Smyrk TC, Heimbach JK.

Liver Transpl. 2015 Feb;21(2):248-57. doi: 10.1002/lt.24041.

18.

Hepatocellular carcinomas within the Milan criteria: predictors of histologic necrosis after drug-eluting beads transarterial chemoembolization.

Odisio BC, Galastri F, Avritscher R, Afonso BB, Segatelli V, Felga GE, Salvalaggio PR, Ensor J, Wallace MJ, Nasser F.

Cardiovasc Intervent Radiol. 2014 Aug;37(4):1018-26. doi: 10.1007/s00270-013-0759-z. Epub 2013 Oct 23. Erratum in: Cardiovasc Intervent Radiol. 2014 Dec;37(6):1648.

PMID:
24149832
19.

Comparison of radiofrequency ablation and transarterial chemoembolization for hepatocellular carcinoma within the Milan criteria: a propensity score analysis.

Hsu CY, Huang YH, Chiou YY, Su CW, Lin HC, Lee RC, Chiang JH, Huo TI, Lee FY, Lee SD.

Liver Transpl. 2011 May;17(5):556-66. doi: 10.1002/lt.22273.

20.

Supplemental Content

Support Center